ArticleClinical diabetes : a publication of the American Diabetes Association2024

Use of Continuous Glucose Monitoring and Glucagon-Like Peptide 1 Receptor Agonist Therapy to Achieve Individualized Treatment Goals in Insulin-Treated People With Type 2 Diabetes: A Case Series and Expert Opinion.

Nicole M Ehrhardt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.